{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:00:47Z","timestamp":1789765247770,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":1076,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jchf.2014.09.009","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T15:45:59Z","timestamp":1422459959000},"page":"202-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated\u00a0Cardiomyopathy"],"prefix":"10.1016","volume":"3","author":[{"given":"Roger M.","family":"Beadle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kuehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bowater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Abozguia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Leyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaheer","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.M.","family":"Wagenmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Frenneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2014.09.009_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More 'malignant' than cancer? Five-year survival following a first admission for\u00a0heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2014.09.009_bib2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJM199511023331806","article-title":"A\u00a0multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure","volume":"333","author":"Rich","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2014.09.009_bib3","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2014.09.009_bib4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/01.CIR.81.4.1260","article-title":"Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent","volume":"81","author":"Cole","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2014.09.009_bib5","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment","volume":"112","author":"Lee","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2014.09.009_bib6","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2014.09.009_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5273(86)90146-4","article-title":"Perhexiline maleate treatment for severe angina pectoris\u2014correlations with pharmacokinetics","volume":"13","author":"Horowitz","year":"1986","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2014.09.009_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jchf.2014.09.009_bib9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(97)06402-7","article-title":"Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium","volume":"351","author":"Bottomley","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2014.09.009_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0140-6736(91)91838-L","article-title":"Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy","volume":"338","author":"Conway","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2014.09.009_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCRESAHA.113.301413","article-title":"Molecular changes after left ventricular assist device support for heart failure","volume":"113","author":"Birks","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2014.09.009_bib12","first-page":"H2167","article-title":"Effects\u00a0of\u00a0ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction","volume":"277","author":"Hugel","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jchf.2014.09.009_bib13","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0022-2828(95)91551-6","article-title":"Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction","volume":"27","author":"Sanbe","year":"1995","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2014.09.009_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1745-6215-12-140","article-title":"Metabolic manipulation in chronic heart failure: study protocol for a randomised controlled trial","volume":"12","author":"Beadle","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.jchf.2014.09.009_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/cs0960373","article-title":"An immunoluminometric assay for N-terminal\u00a0pro-brain natriuretic peptide: development of a test for left ventricular dysfunction","volume":"96","author":"Hughes","year":"1999","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jchf.2014.09.009_bib16","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/01.CIR.97.17.1716","article-title":"Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine\/ATP ratios in humans","volume":"97","author":"Conway","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2014.09.009_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/nbm.701","article-title":"Cramer-Rao bounds: an evaluation tool for quantitation","volume":"14","author":"Cavassila","year":"2001","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jchf.2014.09.009_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0195-668X(03)00199-4","article-title":"The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population","volume":"24","author":"Thackray","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2014.09.009_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of\u00a0Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2014.09.009_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejrad.2008.10.018","article-title":"(31)P magnetic resonance\u00a0spectroscopy to measure in\u00a0vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: experiences at 3T","volume":"73","author":"Shivu","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jchf.2014.09.009_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.fjc.0000190488.77434.f1","article-title":"Dissociation\u00a0between metabolic and efficiency effects of perhexiline in normoxic rat myocardium","volume":"46","author":"Unger","year":"2005","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jchf.2014.09.009_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/14756366.2011.636360","article-title":"NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation","volume":"28","author":"Gatto","year":"2013","journal-title":"J\u00a0Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jchf.2014.09.009_bib23","doi-asserted-by":"crossref","first-page":"e7124","DOI":"10.1371\/journal.pone.0007124","article-title":"Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling","volume":"4","author":"Balgi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2014.09.009_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2013.01.016","article-title":"Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure","volume":"59","author":"Dedkova","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2014.09.009_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97","author":"Gao","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2014.09.009_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehi816","article-title":"Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine\/adenosine triphosphate ratio in patients with heart failure","volume":"27","author":"Fragasso","year":"2006","journal-title":"Eur Heart J"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177914005307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177914005307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:55:01Z","timestamp":1537905301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177914005307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2213177914005307"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2014.09.009","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated\u00a0Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2014.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}